Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$17.78M$17.78MderivedN/M vs Q4 2022 EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$569,924,000+40.0% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Incomederived$88,744,000N/M Operating Cash Flowderived$111,765,000+28.5% Free Cash Flowderived$79,868,000+109.4% ended Dec 31, 2023 · filed Feb 20, 2024 · 51 d after period end